Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis

BackgroundMyelin oligodendrocyte glycoprotein antibody-associated autoimmune disease (MOGAD) is a rare monophasic or relapsing inflammatory demyelinating disease of the central nervous system (CNS) and can mimic multiple sclerosis (MS). The variable availability of live cell-based MOG-antibody assay...

Full description

Bibliographic Details
Main Authors:	Benjamin Vlad, Ina Reichen, Stephan Neidhart, Marc Hilty, Dimitra Lekaditi, Christine Heuer, Amanda Eisele, Mario Ziegler, Markus Reindl, Andreas Lutterotti, Axel Regeniter, Ilijas Jelcic
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Immunology
Subjects:	MOGAD multiple sclerosis cerebrospinal fluid MRZ reaction oligoclonal bands CSF/serum albumin ratio
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1237149/full

Similar Items

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
by: Benjamin Vlad, et al.
Published: (2023-03-01)

Diagnostic significance of intrathecally synthesized immunoglobulins against neurotropic viruses (MRZ-reaction) in diagnosis of multiple sclerosis
by: A. N. Moshnikova, et al.
Published: (2020-02-01)

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis
by: Tilman Hottenrott, et al.
Published: (2018-01-01)

Comparison of Two Different Canine Anti-IgG Antibodies for Assessment of Oligoclonal Bands in Cerebrospinal Fluid and Serum of Dogs via Isoelectric Focusing Followed by an Immunoblot
by: Julia K. Prümmer, et al.
Published: (2022-07-01)

EEG-Delta brushes in DPPX encephalitis – Welcome to the club
by: Christine Heuer, et al.
Published: (2023-01-01)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
by: Tilman Robinson, et al.
Published: (2020-11-01)

Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
by: Julia K Prümmer, et al.
Published: (2023-01-01)

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course
by: Ariel Rechtman, et al.
Published: (2022-03-01)

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22)
by: Samaneh Hosseini
Published: (2023-01-01)

Building an Application that reads Secure Information Stored on the Chip of the Citizen Identity Card in Vietnam
by: Van-Hoan Le, et al.
Published: (2023-02-01)

Do patients with schizophreniform and bipolar disorders show an intrathecal, polyspecific, antiviral immune response? A pilot study
by: Dominique Endres, et al.
Published: (2017-12-01)

The establishment and application of MOG-IgG-mediated complement-dependent in vitro demyelination model
by: Chen Yashuang, Xiao Xiuqing, Wang Shisi, Mo Yongxin, Sun Xiaobo, Zhong Xiaofen, Peng Lisheng
Published: (2022-03-01)

Cognitive fatigability assessment test (cFAST): Development of a new instrument to assess cognitive fatigability and pilot study on its association to perceived fatigue in multiple sclerosis
by: Liliana Barrios, et al.
Published: (2022-08-01)

Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy – a realistic possibility?
by: Ivan Jelcic, et al.
Published: (2017-10-01)

Editorial: MOGAD, current knowledge and future trends
by: Sasitorn Siritho, et al.
Published: (2023-09-01)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
by: Yajun Yao, et al.
Published: (2022-08-01)

Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases – a retrospective cross-sectional study
by: Felix Brauchle, et al.
Published: (2023-06-01)

New-onset refractory status epilepticus due to autoimmune encephalitis after vaccination against SARS-CoV-2: First case report
by: Jana Werner, et al.
Published: (2022-08-01)

Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice
by: Amy E. Wright, et al.
Published: (2024-03-01)

Neuritis optica bilateral asociado anticuerpos anti-glicoproteina de la mielina del oligodendrocito (MOGAD): Reporte de caso
by: Karelys Moreno Arias, et al.
Published: (2023-12-01)

Neuritis optica bilateral asociado anticuerpos anti-glicoproteina de la mielina del oligodendrocito (MOGAD): Reporte de caso
by: Karelys Moreno Arias, et al.
Published: (2023-12-01)

Editorial: Advances in neuromyelitis optica spectrum disorders
by: Yu Cai, et al.
Published: (2022-08-01)

Atypical Adult-Onset Subacute Sclerosing Panencephalitis
by: Lorna Stemberger Marić, et al.
Published: (2020-01-01)

Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease
by: Wenjun Shao, et al.
Published: (2024-03-01)

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing
by: Adrian Budhram, et al.
Published: (2024-03-01)

COVID-19 Vaccine—A Potential Trigger for MOGAD Transverse Myelitis in a Teenager—A Case Report and a Review of the Literature
by: Cristina Oana Mărginean, et al.
Published: (2022-05-01)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
by: Min Shi, et al.
Published: (2023-09-01)

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
by: Chaithra Malli, et al.
Published: (2023-05-01)

Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
by: Giulia Fadda, et al.
Published: (2022-11-01)

The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
by: Ünsal Yılmaz
Published: (2024-02-01)

Case Report: A Case With MOGAD and Anti-NMDAR Encephalitis Overlapping Syndrome Mimicing Radiological Characteristics of CLIPPERS
by: Jia Guo, et al.
Published: (2022-04-01)

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
by: Angelika Bauer, et al.
Published: (2022-11-01)

Clinical Profile and Treatment Outcome in MOGAD: A Single-Center Case-Series Study in Guiyang, China
by: Xiaoyang Lei, et al.
Published: (2022-04-01)

Modeling multiple sclerosis using mobile and wearable sensor data
by: Shkurta Gashi, et al.
Published: (2024-03-01)

Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders
by: Davide Cossu, et al.
Published: (2023-12-01)

A rare presentation of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) as acute hemorrhagic longitudinally extensive transverse myelitis
by: Aniket Nerlekar, et al.
Published: (2023-11-01)

The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature
by: Michał Borończyk, et al.
Published: (2023-08-01)

Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations
by: Alberto Vogrig, et al.
Published: (2023-02-01)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
by: Virginia Rinaldi, et al.
Published: (2022-12-01)

Neuroinflammation: 2021 Update
by: Hans Lassmann
Published: (2021-01-01)